Government body · founded 1965
Centre international de recherche sur le cancer
Lyon, France · iarc.who.int
Part of World Health Organization
- Citations, last 5 years
- 90.7k
- Works, last 5 years
- 3 182
- h-index
- 841
- Scientists listed
- 134
- Grants since 2016
- 88
Grants received
2020–2024 · research · R01
African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus)
Isabel Dos Santos Silva · Centre international de recherche sur le cancer · funded by National Institutes of Health
2020–2021 · research · R01
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2020–2024 · research · R01
African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus)
Isabel Dos Santos Silva · Centre international de recherche sur le cancer · funded by National Institutes of Health
2020–2025 · research · R01
African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus)
Isabel Dos Santos Silva · Centre international de recherche sur le cancer · funded by National Institutes of Health
2020 · grant · HDHL-INTIMIC
The physiological impact of dietary methylglyoxal
Mazda Jenab · Centre international de recherche sur le cancer · funded by Agence Nationale de la Recherche
2020–2022 · research · R03
Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world
Hilary A. Robbins · Centre international de recherche sur le cancer · funded by National Institutes of Health
2020–2024 · research · R01
African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus)
Isabel Dos Santos Silva · Centre international de recherche sur le cancer · funded by National Institutes of Health
2020–2024 · research · R01
African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus): Ghana mentoring supplement
Isabel Dos Santos Silva · Centre international de recherche sur le cancer · funded by National Institutes of Health
2019–2025 · research · Global Health
WHO-IARC (International Agency for Research on Cancer) - to establish baseline HPV prevalence among young women in Uganda prior to introduction of HPV vaccine
Centre international de recherche sur le cancer · funded by Bill and Melinda Gates Foundation
2018–2023 · research · Global Health
WHO-IARC (International Agency for Research on Cancer) - to accelerate a possible transition toward broader use of HPV vaccine as a single-dose regimen by assessing the real-world effectiveness of one dos...
Centre international de recherche sur le cancer · funded by Bill and Melinda Gates Foundation
2018–2023 · research · Global Health
WHO-IARC (International Agency for Research on Cancer) - to enable production of low cost, efficacious HPV vaccine to be made available to GAVI eligible/graduating and other low and middle-income countries
Centre international de recherche sur le cancer · funded by Bill and Melinda Gates Foundation
2017–2021 · research · R01
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2017–2021 · research · R01
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2017–2021 · research · R01
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2017–2021 · research · R01
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2017–2022 · research · R01
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2018 · cooperative agreement · UH2
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries
Rolando Herrero · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2023 · cooperative agreement · UH3
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2018 · cooperative agreement · UH2
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Rengaswamy Sankaranarayanan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2022 · cooperative agreement · UH3
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries
Maribel Almonte · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2024 · cooperative agreement · UH3
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2020 · research · R01
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
Pietro Ferrari · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2023 · cooperative agreement · UH3
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries
Maribel Almonte · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2021 · cooperative agreement · UH3
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2024 · cooperative agreement · UH3
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2021 · cooperative agreement · UH3
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2021 · cooperative agreement · UH3
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2022 · cooperative agreement · UH3
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries
Maribel Almonte · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2020 · research · R01
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
Pietro Ferrari · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2019 · cooperative agreement · UH2
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries
Rolando Herrero · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2018 · cooperative agreement · UH2
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
Partha Basu · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2023 · cooperative agreement · UH3
Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries
Maribel Almonte · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2021 · research · R01
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
Pietro Ferrari · Centre international de recherche sur le cancer · funded by National Institutes of Health
2016–2020 · research · R01
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
Pietro Ferrari · Centre international de recherche sur le cancer · funded by National Institutes of Health
2015–2021 · cooperative agreement · U01
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
Paul Joseph Brennan · Centre international de recherche sur le cancer · funded by National Institutes of Health
2012–2020 · grant · Global Development
WHO-IARC (International Agency for Research on Cancer) - to reduce the burden of cervical cancer among women worldwide by promoting, and appropriately evaluating the impact of human papillomavirus (HPV) v...
Centre international de recherche sur le cancer · funded by Bill and Melinda Gates Foundation
2007–2022 · research · Global Development|Global Health
WHO-IARC (International Agency for Research on Cancer) - to verify effectiveness and safety of 2 vs 3 doses of HPV vaccine in preventing cervical cancer in a population in a developing country and to faci...
Centre international de recherche sur le cancer · funded by Bill and Melinda Gates Foundation
1985–2026 · research · R01
IARC Monographs on the Identification of Carcinogenic Hazards to Humans
Mary K. Schubauer-Berigan · Centre international de recherche sur le cancer · funded by National Institutes of Health
1985–2020 · cooperative agreement · U01
Evaluation of Carcinogenic Risks to Humans
Kurt Straif · Centre international de recherche sur le cancer · funded by National Institutes of Health
1985–2021 · cooperative agreement · U01
Evaluation of Carcinogenic Risks to Humans
Mary K. Schubauer-Berigan · Centre international de recherche sur le cancer · funded by National Institutes of Health
